BIA member Brainomix recently celebrated the successful completion of a Β£14 million Series C funding round to advance its groundbreaking #AI imaging technology. π
#Brainomix CEO Dr. Michalis Papadakis shares insights into the company's origins and discusses its future trajectory β‘οΈ ow.ly/FwHe50VrySn
31.03.2025 14:13 β π 1 π 1 π¬ 0 π 0
My 1st post! As a member of the @who.int taskforce of #AMR survivors I am pleased to bring the #AMR threat to life through patient stories & lived experiences, to raise awareness & drive action. Wishing you health through the festive period & many happy & healthy years to come, free of infection.
23.12.2024 19:24 β π 3 π 2 π¬ 0 π 0
Just finding us here? Endpoints News has a starter pack with our journalists so you can follow the team!
go.bsky.app/NzDRUhL
17.12.2024 19:38 β π 20 π 6 π¬ 2 π 0
Brilliant - makes it so easy to find and follow you all
17.12.2024 20:52 β π 0 π 0 π¬ 0 π 0
Guardian science correspondent
The award-winning UK trade association for the innovative life sciences and biotech industry.
Microbiologist, interested in alternate bacterial lifestyles - cell wall deficiency, biofilms, AMR
βοΈ Contact and complaints: https://www.theguardian.com/info/2013/may/26/contact-guardian-australia?CMP=aus_bsky
π¨ Newsletters: http://theguardian.com/emails?CMP=aus_bsky
π° Contribute: http://bit.ly/gdnausupport
The need for independent journalism has never been greater. Become a Guardian supporter https://support.theguardian.com
πΊπΈ Guardian US https://bsky.app/profile/us.theguardian.com
π¦πΊ Guardian Australia https://bsky.app/profile/australia.theguardian.com
#AntimicrobialResistance Patient Advocate β’ Chair @WHO Taskforce of AMR Survivors β’ @AfricaCDC Civil Society Champion β’ Founder of @theAMRnarrative
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
Senior editor, Endpoints News
features editor @endpts.com / fall 2021 fellow
@ksjatmit.bsky.social
Writing (and editing) stories on rare disease medicine, diagnostics and China
Reach out privately on Signal: jaredwhitlock.73
Biopharma reporter at Endpoints News | nicole@endpointsnews.com
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum. Message me on Signal: maxgelman.37
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or maxbayer.10 on Signal. he/him
reporting on drugs and biotechs @endpoints β’ email me: lwu@endpointsnews.com β’ Signal: leileiwu.24 β’ βοΈ
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky
Priors: Bloomberg News + the Covid vaccine tracker. CQ.
Reporter @ Endpoints News
Covering biotech, pharma, AI, and more β the future of medicine
adunn@endpointsnews.com
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | ππ³οΈβπππ»ββοΈποΈπ¨
A writer, university instructor and recovering spy.
Reporter at STAT. The Harry Kane of biotech. Dog β€οΈer. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.